| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Standard Chemical & Pharmaceutical Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$78.70 |
| 52 Week High | NT$79.20 |
| 52 Week Low | NT$58.10 |
| Beta | 0.15 |
| 11 Month Change | 6.50% |
| 3 Month Change | 24.92% |
| 1 Year Change | 22.40% |
| 33 Year Change | 106.02% |
| 5 Year Change | 149.05% |
| Change since IPO | 262.56% |
Recent News & Updates
Recent updates
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70
Jul 14
If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late
Apr 13A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)
Mar 14Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?
Mar 01Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?
Feb 16
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?
Feb 03Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Jan 19Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today
Jan 04Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?
Dec 22A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)
Dec 08Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly
Nov 26Shareholder Returns
| 1720 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 7.1% | -1.8% | -2.3% |
| 1Y | 22.4% | 13.6% | 31.2% |
Return vs Industry: 1720 exceeded the TW Pharmaceuticals industry which returned 13.6% over the past year.
Return vs Market: 1720 underperformed the TW Market which returned 31.2% over the past year.
Price Volatility
| 1720 volatility | |
|---|---|
| 1720 Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.5% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 1720 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1720's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | n/a | Tzu-Ting Fan | www.standard.com.tw |
Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients.
Standard Chemical & Pharmaceutical Co. Ltd. Fundamentals Summary
| 1720 fundamental statistics | |
|---|---|
| Market cap | NT$14.06b |
| Earnings (TTM) | NT$876.61m |
| Revenue (TTM) | NT$6.36b |
16.0x
P/E Ratio2.2x
P/S RatioIs 1720 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1720 income statement (TTM) | |
|---|---|
| Revenue | NT$6.36b |
| Cost of Revenue | NT$3.60b |
| Gross Profit | NT$2.76b |
| Other Expenses | NT$1.88b |
| Earnings | NT$876.61m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.91 |
| Gross Margin | 43.38% |
| Net Profit Margin | 13.78% |
| Debt/Equity Ratio | 11.6% |
How did 1720 perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield55%
Payout RatioDoes 1720 pay a reliable dividends?
See 1720 dividend history and benchmarks| Standard Chemical & Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Aug 01 2024 |
| Dividend Pay Date | Aug 30 2024 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 34 days |
Does 1720 pay a reliable dividends?
See 1720 dividend history and benchmarks